Metis Pharma

IPO

剂泰科技(北京)股份有限公司

Hangzhou, China · Founded 2019 · $236.0M raised

Headquarters
Hangzhou
Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$236.0M
Last Round
$150.0M Series BApr 2022
Rounds
2

About

METiS Pharmaceuticals is an AI-driven innovative biotechnology company that harnesses targeted drug delivery technology to develop more effective drugs for patients. Through the integration of cutting-edge artificial intelligence with traditional pharmaceutical R&D, METiS accelerates the discovery and development of innovative drugs in a more efficient and precise manner, while leveraging its core technology platforms to support the broader pharmaceutical ecosystem. The company has developed the AiLNP platform for AI-designed nanoparticle drug delivery and has received FDA Orphan Drug designation for its hepatocellular carcinoma candidate.

Summary

Metis Pharma is an Artificial Intelligence company based in Hangzhou, China, founded in 2019. It has raised $236.0M in total across 2 rounds, most recently a $150.0M Series B round in Apr 2022. Investors include PICC Capital Investment, China Life Equity and Frees Fund.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2026
$268.2M

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Metis Pharma on Indexed.vc
<a href="https://indexed.vc/companies/metis-pharma"><img src="https://indexed.vc/api/badge/company/metis-pharma" alt="Metis Pharma on Indexed.vc" width="260" height="76" /></a>